Cargando…

Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring

PURPOSE: To investigate whether a more frequent monitoring of the absolute neutrophil counts (ANC) during myelosuppressive chemotherapy, together with model-based predictions, can improve therapy management, compared to the limited clinical monitoring typically applied today. METHODS: Daily ANC in c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Netterberg, Ida, Nielsen, Elisabet I., Friberg, Lena E., Karlsson, Mats O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532422/ https://www.ncbi.nlm.nih.gov/pubmed/28656382 http://dx.doi.org/10.1007/s00280-017-3366-x

Ejemplares similares

A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection
por: Sadiq, Muhammad W., et al.
Publicado: (2016)

Tumor Time‐Course Predicts Overall Survival in Non‐Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow‐Up Time
por: Netterberg, Ida, et al.
Publicado: (2020)

A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6
por: Thorsted, Anders, et al.
Publicado: (2019)

A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients
por: Netterberg, Ida, et al.
Publicado: (2018)

Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer
por: Zheng, Ziming, et al.
Publicado: (2022)

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk
por: Nguyen, Christine M., et al.
Publicado: (2011)

Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
por: Saggam, Akash, et al.
Publicado: (2022)

Development of a Machine Learning-Based Prediction Model for Chemotherapy-Induced Myelosuppression in Children with Wilms’ Tumor
por: Li, Mujie, et al.
Publicado: (2023)

Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models
por: Ibrahim, Eman I. K., et al.
Publicado: (2023)

Piperacillin/tazobactam Induced Myelosuppression
por: Lee, Kirsty Wai Chung, et al.
Publicado: (2009)

Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice
por: Basile, Lena A, et al.
Publicado: (2008)

Translational Modeling of Drug‐Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor
por: Collins, TA, et al.
Publicado: (2017)

Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?
por: Parrott, Jessica, et al.
Publicado: (2017)

Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in “real‐world” administration
por: Salem, Ahmed M., et al.
Publicado: (2023)

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
por: Kumar, R, et al.
Publicado: (2009)

Myelosuppression by sunitinib is flt-3 genotype dependent
por: van Erp, N P, et al.
Publicado: (2010)

Sleeping through the storm: Preventing myelosuppression with quizartinib
por: Taylor, Samuel J., et al.
Publicado: (2017)

Antineoplastics: Myelosuppression and COVID-19: case report
Publicado: (2020)

Palbociclib: Myelosuppression and gastrointestinal reactions: case report
Publicado: (2022)

Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia
por: Jost, Felix, et al.
Publicado: (2019)

Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery
por: Chen, Yuxin, et al.
Publicado: (2022)

Promotion of Myelopoiesis in Myelosuppressed Mice by Ganoderma lucidum Polysaccharides
por: Zhu, Xiao-Ling, et al.
Publicado: (2012)

Multiple drugs: Aseptic Meningitis and myelosuppression: case report
Publicado: (2022)

Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan
por: Gao, Yiqiao, et al.
Publicado: (2019)

Cognitive behavioral therapy for frequent attenders in primary care
por: Strömbom, Ylva, et al.
Publicado: (2018)

Clinical review: Continuous and simplified electroencephalography to monitor brain recovery after cardiac arrest
por: Friberg, Hans, et al.
Publicado: (2013)

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors
por: Centanni, Maddalena, et al.
Publicado: (2022)

Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
por: Gorchynski, Julie, et al.
Publicado: (2008)

Hematopoietic Effects of Paeoniflorin and Albiflorin on Radiotherapy-Induced Myelosuppression Mice
por: Zhu, Yingli, et al.
Publicado: (2016)

New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression
por: Gupta, Vineet, et al.
Publicado: (2013)

TGFβ restores hematopoietic homeostasis after myelosuppressive chemotherapy
por: Brenet, Fabienne, et al.
Publicado: (2013)

Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
por: Rafi, Mohammad, et al.
Publicado: (2018)

ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression
por: Drenberg, CD, et al.
Publicado: (2016)

An Early Myelosuppression in the Acute Mouse Sepsis Is Partly Outcome-Dependent
por: Skirecki, Tomasz, et al.
Publicado: (2021)

Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients
por: Kuriakose, Jolly, et al.
Publicado: (2022)

Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
por: Grisic, Ana-Marija, et al.
Publicado: (2022)

Effect of salidroside on bone marrow haematopoiesis in a mouse model of myelosuppressed anaemia
por: Chen, Xiaoyan, et al.
Publicado: (2019)

Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel
por: Krishnan, Sreenath M., et al.
Publicado: (2021)

Compatibility effects of ginseng and Ligustrum lucidum Ait herb pair on hematopoietic recovery in mice with cyclophosphamide-induced myelosuppression and its material basis
por: Han, Jiahong, et al.
Publicado: (2020)

A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer
por: Park, Kyemyung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5f3983acsov656mpr2as9dn0a6